The earnings call reflected significant challenges, including a notable decline in revenue and continued issues with TRICARE payments, overshadowing positive steps like cost reductions and new leadership. Despite strategic efforts to refocus and reduce costs, the financial performance and current market conditions suggest substantial headwinds.

Company Guidance -

Q3 2025

During the Zynex Second Quarter 2025 Earnings Conference Call, several key metrics and strategic decisions were discussed. The company reported net revenue of $22.3 million, a decline from $49.9 million in the same quarter of 2024, primarily due to a temporary payment suspension from TRICARE and a reduction in order growth. Zynex achieved a gross profit of $15.2 million, representing 68% of revenue, compared to 80% in Q2 2024. The company experienced a net loss of $20 million, with a significant portion due to a $10.3 million noncash tax allowance adjustment. The company aims to reduce expenses by approximately $40 million annually through staff reductions and operational realignment, including a 14% decrease in overall staff and the elimination of nearly 90 corporate roles. Zynex collected $26 million in cash during the quarter and plans to continue reducing cash burn. The financial outlook remains cautious, with quarterly guidance suspended as the company transitions to new leadership, including the appointment of Steven Dyson as CEO. The company is optimistic about its NiCO pulse oximeter, submitted to the FDA, with a potential market impact anticipated in the coming months.

Cost Reduction Initiatives

The company announced a reduction in overall expenses of approximately $40 million annualized through better supply chain management and a more diversified prescriber and payer customer base.

Introduction of New CEO

Steven Dyson was announced as the new CEO, bringing over 25 years of experience in the medical technology sector, which is expected to help refocus business strategy towards growth.

FDA Submission for NiCO Pulse Oximeter

The company submitted its NiCO laser pulse oximeter to the FDA, marking a potential milestone in the pulse oximetry market by addressing accuracy issues with current technologies.

Zynex (ZYXI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ZYXI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 23, 2025	2025 (Q3)	-0.17 / -	0.07	―	―	―
Jul 31, 2025	2025 (Q2)	-0.20 / -0.66	0.04	-1750.00% (-0.70)	―
Apr 29, 2025	2025 (Q1)	-0.24 / -0.33	0	―	―
Mar 11, 2025	2024 (Q4)	0.09 / -0.02	0.04	-150.00% (-0.06)	―
Oct 24, 2024	2024 (Q3)	0.06 / 0.07	0.1	-30.00% (-0.03)	―
Jul 25, 2024	2024 (Q2)	0.08 / 0.04	0.09	-55.56% (-0.05)	―
Apr 30, 2024	2024 (Q1)	0.03 / 0.00	0.04	―	―
Feb 29, 2024	2023 (Q4)	0.17 / 0.04	0.2	-80.00% (-0.16)	―
Oct 26, 2023	2023 (Q3)	0.09 / 0.10	0.13	-23.08% (-0.03)	―
Jul 27, 2023	2023 (Q2)	0.04 / 0.09	0.08	12.50% (<+0.01)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ZYXI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$2.23	$1.26	-43.50%
Apr 29, 2025	$2.23	$1.66	-25.56%
Mar 11, 2025	$7.00	$3.41	-51.29%
Oct 24, 2024	$8.59	$9.12	+6.17%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Zynex (ZYXI) report earnings?

Zynex (ZYXI) is schdueled to report earning on Oct 23, 2025, Before Open (Confirmed).

What is Zynex (ZYXI) earnings time?

Zynex (ZYXI) earnings time is at Oct 23, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ZYXI EPS forecast?

ZYXI EPS forecast for the fiscal quarter 2025 (Q3) is -0.17.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing